Article Versions Notes

Lappano R, Mallet C, Rizzuti B, Grande F, Galli GR, Byrne C, Broutin I, Boudieu L, Eschalier A, Jacquot Y, et al. The Peptide ERα17p Is a GPER Inverse Agonist that Exerts Antiproliferative Effects in Breast Cancer Cells. Cells. 2019; 8(6):590. https://doi.org/10.3390/cells8060590

Lappano, Rosamaria, Christophe Mallet, Bruno Rizzuti, Fedora Grande, Giulia Raffaella Galli, Cillian Byrne, Isabelle Broutin, Ludivine Boudieu, Alain Eschalier, Yves Jacquot, and et al. 2019. "The Peptide ERα17p Is a GPER Inverse Agonist that Exerts Antiproliferative Effects in Breast Cancer Cells" Cells 8, no. 6: 590. https://doi.org/10.3390/cells8060590

Lappano, R., Mallet, C., Rizzuti, B., Grande, F., Galli, G. R., Byrne, C., Broutin, I., Boudieu, L., Eschalier, A., Jacquot, Y., & Maggiolini, M. (2019). The Peptide ERα17p Is a GPER Inverse Agonist that Exerts Antiproliferative Effects in Breast Cancer Cells. Cells, 8(6), 590. https://doi.org/10.3390/cells8060590